iNovacia will continue to support external customers.

During 2010 and 2011, iNovacia has successfully been providing drug discovery services to Kancera, primarily within identification and optimization of novel and competitive lead series in Kancera's preclinical cancer programs. The now completed acquisition of iNovacia's highly regarded and validated organization brings further credibility to Kancera's effort to develop cutting-edge cancer programs with both quality and speed.

Full press release